InsidersTradesSigma
Follow the VISEN Pharmaceuticals - B stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, VISEN Pharmaceuticals - B has logged 2 insider filings. Market capitalisation: €2.2bn. The latest transaction was disclosed on 28 April 2026 (Sale). Among the most active insiders: LU AN-BANG. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,400 of 29,063 companies
10.7
score / 100
Value12
Quality9
FCF yld-20%
Earn yld-11%
EV/EBITDA·
ROE-51%
Gross mgn12%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 April 2026
Declarations2 total
108,750 sharesShareXHKGHKEX:DA20260427E00462
3,500,000 sharesShareXHKGHKEX:DA20260427E00463
2 of 2 declarations
Acerca de VISEN Pharmaceuticals - B
VISEN Pharmaceuticals - B es una empresa centrada en el desarrollo de tratamientos innovadores en el sector sanitario y farmacéutico. Cotiza en la Bolsa de Hong Kong (XHKG).